Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act

A. Tefferi

doi:10.1038/bmt.2009.193

Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act

A. Tefferi

Hematology

Research output: Contribution to journal › Editorial › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	419-421
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	45
Issue number	3
DOIs	https://doi.org/10.1038/bmt.2009.193
State	Published - 2010

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/bmt.2009.193

Cite this

@article{e62007c0d5c4426a8b71c243065ebb6f,

title = "Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act",

author = "A. Tefferi",

year = "2010",

doi = "10.1038/bmt.2009.193",

language = "English (US)",

volume = "45",

pages = "419--421",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis

T2 - The risk-benefit balancing act

AU - Tefferi, A.

PY - 2010

Y1 - 2010

UR - http://www.scopus.com/inward/record.url?scp=77949366004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949366004&partnerID=8YFLogxK

U2 - 10.1038/bmt.2009.193

DO - 10.1038/bmt.2009.193

M3 - Editorial

C2 - 20216545

AN - SCOPUS:77949366004

SN - 0268-3369

VL - 45

SP - 419

EP - 421

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 3

ER -

Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this